Friday, September 28, 2018

Corcept granted orphan status for pancreatic cancer treatment


The FDA granted Corcept Therapeutics orphan status for relacorilant, its treatment of pancreatic cancer
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.